IDEXX Laboratories, Inc. IDXX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.28% | 21.54% | 12.19% | -9.62% | -6.59% |
| Total Depreciation and Amortization | -1.19% | 8.94% | -2.68% | 5.72% | 2.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.47% | -38.20% | -23.14% | -53.29% | 459.80% |
| Change in Net Operating Assets | 236.26% | 36.56% | -628.58% | 185.11% | 87.82% |
| Cash from Operations | 29.54% | 30.39% | -25.16% | -11.58% | 116.61% |
| Capital Expenditure | -17.38% | 22.94% | -8.66% | 5.40% | 8.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 601.18% | 45.51% | -219.63% | 109.48% | -3,002.32% |
| Cash from Investing | -873.09% | 23.99% | -19.25% | 37.31% | -33.43% |
| Total Debt Issued | -309.09% | -108.33% | -31.61% | 255.65% | -147.78% |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -4.36% | 81.23% | 1.63% | -64.94% | 194.11% |
| Repurchase of Common Stock | 67.64% | 4.01% | -52.04% | 1.02% | 29.14% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 38.24% | -53.80% | 40.56% | -13.53% | -89.16% |
| Foreign Exchange rate Adjustments | -131.94% | 91.18% | -3,300.00% | 95.91% | -104.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 116.77% | -117.57% | 172.81% | -164.48% | 6,882.69% |